On June 14, 2022, VRBPAC (FDA advisors) will meet to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to children and adolescents 6 years through 17 years of age.  On June 15, 2022, they will discuss amending the EUA of […]